SCHEMBL5317002

SCHEMBL5317002

CN1CN=c2c(ncn2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)=C1N.CN1CN=c2c(ncn2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)=C1N

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.50
ALDH1A1 P00352 2/20 0.50
HTT P42858 2/20 0.50
BLM P54132 2/20 0.50
LMNA P02545 2/20 0.50
GMNN O75496 1/20 0.50
NFKB1 P19838 1/20 0.50
DNMT1 P26358 1/20 0.50
THPO P40225 1/20 0.50
MTOR P42345 1/20 0.50
RAB9A P51151 1/20 0.50
HBB P68871 1/20 0.50
PMP22 Q01453 1/20 0.50
KDM4E B2RXH2 2/20 0.49
TDP1 Q9NUW8 1/20 0.49
MAPT P10636 1/20 0.49
ADORA3 P0DMS8 3/20 0.48
ADORA2A P29274 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
ADORA2B P29275 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL40771 1.00 TP53 (0.50) TP53ALDH1A1HTTBLMLMNA
SCHEMBL16348679 0.91 TP53 (0.41) TP53ALDH1A1HTTBLMLMNA
SCHEMBL5950179 0.89 MEN1 (0.46) TP53ALDH1A1HTTBLMLMNA
Gamma-Aminobutyric Acid SCHEMBL12610338 0.89 TP53 (0.45) TP53ALDH1A1HTTBLMLMNA
SCHEMBL6704178 0.87 TP53 (0.51) TP53ALDH1A1HTTBLMLMNA
SCHEMBL41683 0.87 KDM4E (0.47) TP53ALDH1A1HTTBLMLMNA
SCHEMBL136036 0.87 TP53 (0.51) TP53ALDH1A1HTTBLMLMNA
SCHEMBL3208247 0.87 TP53 (0.51) TP53ALDH1A1HTTBLMLMNA
SCHEMBL8840651 0.86 ALDH1A1 (0.45) TP53ALDH1A1HTTBLMLMNA
SCHEMBL17441586 0.84 ADORA2A (0.47) TP53ALDH1A1HTTBLMLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190214145-A1 Method and systems for creating and screening patient metabolite profile to diagnose current medical condition, diagnose current treatment state and recommend new treatment regimen KUREK ITZHAK (US) 2019-07-11 US disclosed
WO-2007087541-A2 ASSAYS FOR S-ADENOSYLMETHIONINE-DEPENDENT METHYLTRANSFERASES WASHINGTON STATE UNIVERSITY RESEARCH FOUNDATION (US) 2007-08-02 WO disclosed